Dengue fever is an infectious disease that the World Health Organization (WHO) named as one of the top 10 threats to global health in 2019. However, with no effective treatment, approximately half of the world's population is currently at risk of dengue fever, with an estimated 100 to 400 million people infected each year.
According to the WHO, before 1970, dengue was endemic in nine countries, mainly in Southeast Asia, but has now spread to more than 100 countries across a wide area in Latin America and the African continent. One of the reasons for the spread is the impact of climate change.
In this seminar, we will provide an overview of the intersection between climate change & health, and present the efforts of the private company to develop effective vaccines against infection, followed by a discussion with experts.
Through this seminar, representatives from the public and private sectors, as well as international organizations, will influence the audience in the seminar by absorbing knowledge and best practices and, creating possible cross-sector partnerships to develop workable solutions to address the increasing threat of dengue fever amidst climate challenges and health.
Event Details
COP29 Japan Pavilion (Simultaneous Online Streaming available)
Presentation Materials
Event Details
Japan Pavilion in the Blue Zone at COP29, Baku, Azerbaijan
Presentation Materials
Opening Remarks | |||
MATSUZAWA Yutaka, Vice-Minister for Global Environmental Affairs, Ministry of the Environment, Japan | |||
Keynote | |||
Maria Neira, Director of the Department of Public Health and Environment, WHO | |||
Presentation | |||
OHYABU Takako, Global Corporate Affairs, Takeda Pharmaceutical Company Limited Chief Global Corporate Affairs and Sustainability Officer | |||
Panel Discussion | |||
HAISA Yukihiro, Director, Climate Change Science and Adaptation Office, Global Environment Bureau, MOEJ | |||
Derek Wallace, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited President, Global Vaccine Business Unit | |||
Anamaria Bejar, GAVI Director, Public Policy Engagement | |||
Danilo Moura, Programme Specialist – Climate, Environment, and DRR (Disaster Risk Reduction) UNICEF Brasil | |||
TAKAHASHI Junichi, Director, Office of Global Health Cooperation, Ministry of Health, Labour and Welfare of Japan | |||
Closing remarks | |||
HAISA Yukihiro, Director, Climate Change Science and Adaptation Office, Global Environment Bureau, MOEJ |